Nwam »

Corvus Pharmaceuticals shares owned by Nwam

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Nwam from 13F filings

Historical chart of Nwam investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Nwam consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Nwam

Quarter filed Position value Share count Share price at filing
2024-09-30 $53k 10k 5.28

More positions owned by Nwam

Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Rus 1000 Grw Etf (IWF)
United Parcel Service CL B (UPS)
Costco Wholesale Corporation (COST)
Ishares Tr Core S&p Ttl Stk (ITOT)
Tesla Motors (TSLA)
Exxon Mobil Corporation (XOM)

View all positions for Nwam

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
Point72 Asset Management
Samlyn Capital
Vanguard Group
BlackRock
Geode Capital Management
BlackRock
Renaissance Technologies
Morgan Stanley
Schonfeld Strategic Advisors
Marshall Wace
Susquehanna International
Ikarian Capital
Citadel Advisors
Connor, Clark & Lunn Investment Management

View all funds holding Corvus Pharmaceuticals